RxDoctor Payments Data

Joshua Lane, MD

MOHS-Micrographic Surgery · Columbus, GANPI 1336146091

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 96.4% of the total across 187 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 39.6% of the total. 2025 is the largest year on record at $1,428, more than ten times the $90 reported in 2019. That places this record below the midpoint for mohs-micrographic surgery clinicians in GA, where the typical reported total is $3,443.

$4,095in general payments, 2019–2025

Across 187 payments — averaging $21.90 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Sanofi$467
  • Regeneron Healthcare Solutions, Inc.$435
  • Galderma Laboratories, L.p.$253
  • Dermavant Sciences, Inc.$215
  • LEO Pharma Inc.$207
  • plus $895 from 13 others
$1,200,778in research payments, 2019–2025

Across 218 payments — averaging $5508.16 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • AbbVie$811K
  • Incyte Corporation$317K
  • Amgen$39K
  • Sanofi US Services Inc.$19K
  • Pfizer$12K
  • E.r. Squibb & Sons, L.L.C.$1K

What the payments were for

  • Speaking & faculty fees$221%
  • Food & beverage$3,94796%
  • Education$1263%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,095 in reported general payments places this provider in the 50th percentile of 40 mohs-micrographic surgery providers in Georgia.

See all mohs-micrographic surgery providers in Georgia

Medicare billing

Part B allowed, 2024
$1,132,174
Medicare patients
854
Services billed
4,816

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OdomzoSonidegib Phosphate52$682,084
Dupixent PenDupilumab11$40,868
Clobetasol Propionate122$5,759
Fluorouracil69$4,727
Triamcinolone Acetonide72$1,361
Doxycycline Hyclate73$1,130
Desonide17$790
Clindamycin Phosphate28$697
Ketoconazole33$456
Fluocinonide13$440
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen25$148
Doxycycline Monohydrate13$118
Cephalexin21$69

Paid to pharmacies, not to this prescriber.

Other mohs-micrographic surgery in Columbus

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →